JMISMDL Jmi Syringes & Medical Devices Ltd.
Pharmaceuticals & Chemicals
Tk 131.9 as of 2026-11-12 14:06:14
Rank 140 of all scored
Data completeness 80%
Data completeness 80%
Override: Avoid. Negative EPS.
Score breakdown
Consistency 67
Profitability 16
Solvency 100
Valuation 30
Weights: consistency 30%, profitability 30%, solvency 20%, valuation 20%; then risk flags add or subtract points. Full method
Why this score
Strengths
- Consistency EPS grew in 3 of 4 years
- Consistency Paid a dividend every year (5/5)
- Solvency Practically debt-free (loan risk cannot hurt it)
Concerns
- Consistency Net loss in 1 of the last 5 years
- Profitability Average ROE only 0.54% (below 10%: capital not working hard)
- Profitability Net profit shrinking 15.74% a year
- Valuation No P/E: the company is loss-making
Risk flags
- Mid cap (Tk 200-1,000 cr)
- Thin trading (last day ~Tk 0.19 cr)
Valuation
P/E
P/E audited
P/E current
P/B
NAV per share
EPS (last audited year)
Graham fair value
Margin of safety
52-week range
24.6% above the low, 19.3% below the high. Near the low is only interesting if profit is intact (see concerns above) and the fall has a temporary cause.
Quality and growth
ROE
ROE avg
ROE min
Profit CAGR
Profit YoY
Net profit
EPS up
Loss years (last ~5)
Dividends and safety
Div years
Dividend yield
Payout
Cash div
D/E
Loans/MCap
Size, liquidity and ownership
MCap
Free float
Daily turnover
Sponsor %
Inst. %
Public %
Foreign %
Shareholding
- Sponsor/director 79.7%
- Institution 5.7%
- Public 14.7%
Audited history
| Year | EPS (Tk) | NAV/share | Net profit (cr) | Cash div % | Bonus % |
|---|---|---|---|---|---|
| 2021 | 4.03 | 122.7 | 9 | 30 | 0 |
| 2022 | 4.55 | 124.25 | 10 | 0 | 36 |
| 2023 | -4.99 | 86.37 | -15 | 10 | 0 |
| 2024 | 1.29 | 86.66 | 4 | 10 | 0 |
| 2025 | 1.49 | 87.23 | 4 | 10 | 0 |
Fiscal year ends June. EPS, NAV and profit are as audited by the company and published by DSE. Financials last fetched: 14/11/2026.
Shariah screen (partial)
Business screen and the debt ratio (loans / market cap 1%, limit 33%) are automated. Interest income (under 5% of revenue) and cash/investment ratios must be checked in the annual report.
Educational, not investment advice. Verify on DSE and StockNow before making any decision.